Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.

Altered methionine metabolism is associated with weight gain in obesity. The methionine adenosyltransferase (MAT), catalyzing the first reaction of the methionine cycle, plays an important role regulating lipid metabolism. However, its role in obesity, when a plethora of metabolic diseases occurs, i...

Descripción completa

Detalles Bibliográficos
Autores: Sáenz de Urturi, Diego, Buqué, Xabier, Porteiro, Begoña, Folgueira, Cintia, Mora, Alfonso, Delgado, Teresa C, Prieto-Fernández, Endika, Olaizola, Paula, Gómez-Santos, Beatriz, Apodaka-Biguri, Maider, González-Romero, Francisco, Nieva-Zuluaga, Ane, Ruiz de Gauna, Mikel, Goikoetxea-Usandizaga, Naroa, García-Rodríguez, Juan Luis, Gutierrez de Juan, Virginia, Aurrekoetxea, Igor, Montalvo-Romeral, Valle, Novoa, Eva M, Martín-Guerrero, Idoia, Varela-Rey, Marta, Bhanot, Sanjay, Lee, Richard, Banales, Jesus M, Syn, Wing-Kin, Sabio, Guadalupe, Martínez-Chantar, María L, Nogueiras, Rubén, Aspichueta, Patricia
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/15706
Acceso en línea:http://hdl.handle.net/20.500.12105/15706
Access Level:acceso abierto
Palabra clave:Adipose Tissue, Brown
Insulin Resistance
Methionine Adenosyltransferase
Obesity
Oligonucleotides, Antisense
Animals
Energy Metabolism
Liver
Mice
NF-E2-Related Factor 2
id ES_b7e979b4ea981e9e58d30bcb3a4bc7e1
oai_identifier_str oai:repisalud.isciii.es:20.500.12105/15706
network_acronym_str ES
network_name_str España
repository_id_str
spelling Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.Sáenz de Urturi, DiegoBuqué, XabierPorteiro, BegoñaFolgueira, CintiaMora, AlfonsoDelgado, Teresa CPrieto-Fernández, EndikaOlaizola, PaulaGómez-Santos, BeatrizApodaka-Biguri, MaiderGonzález-Romero, FranciscoNieva-Zuluaga, AneRuiz de Gauna, MikelGoikoetxea-Usandizaga, NaroaGarcía-Rodríguez, Juan LuisGutierrez de Juan, VirginiaAurrekoetxea, IgorMontalvo-Romeral, ValleNovoa, Eva MMartín-Guerrero, IdoiaVarela-Rey, MartaBhanot, SanjayLee, RichardBanales, Jesus MSyn, Wing-KinSabio, GuadalupeMartínez-Chantar, María LNogueiras, RubénAspichueta, PatriciaAdipose Tissue, BrownInsulin ResistanceMethionine AdenosyltransferaseObesityOligonucleotides, AntisenseAnimalsEnergy MetabolismLiverMiceNF-E2-Related Factor 2Altered methionine metabolism is associated with weight gain in obesity. The methionine adenosyltransferase (MAT), catalyzing the first reaction of the methionine cycle, plays an important role regulating lipid metabolism. However, its role in obesity, when a plethora of metabolic diseases occurs, is still unknown. By using antisense oligonucleotides (ASO) and genetic depletion of Mat1a, here, we demonstrate that Mat1a deficiency in diet-induce obese or genetically obese mice prevented and reversed obesity and obesity-associated insulin resistance and hepatosteatosis by increasing energy expenditure in a hepatocyte FGF21 dependent fashion. The increased NRF2-mediated FGF21 secretion induced by targeting Mat1a, mobilized plasma lipids towards the BAT to be catabolized, induced thermogenesis and reduced body weight, inhibiting hepatic de novo lipogenesis. The beneficial effects of Mat1a ASO were abolished following FGF21 depletion in hepatocytes. Thus, targeting Mat1a activates the liver-BAT axis by increasing NRF2-mediated FGF21 secretion, which prevents obesity, insulin resistance and hepatosteatosis.Nature Publishing GroupAgencia Estatal de Investigación (España)Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)Fundación LillyAsociación Española Contra el CáncerComunidad de Madrid (España)Fundación La CaixaMinisterio de Economía, Innovación y Competitividad (España)Fundación BBVAXunta de Galicia (España)20232023-03-2720222022-03-0120222022-03-01journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/20.500.12105/15706reponame:Repisaludinstname:Instituto de Salud Carlos III (ISCIII)Inglésengopen accesshttp://purl.org/coar/access_right/c_abf2Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repisalud.isciii.es:20.500.12105/157062026-06-12T12:43:37Z
dc.title.none.fl_str_mv Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
title Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
spellingShingle Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
Sáenz de Urturi, Diego
Adipose Tissue, Brown
Insulin Resistance
Methionine Adenosyltransferase
Obesity
Oligonucleotides, Antisense
Animals
Energy Metabolism
Liver
Mice
NF-E2-Related Factor 2
title_short Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
title_full Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
title_fullStr Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
title_full_unstemmed Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
title_sort Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
dc.creator.none.fl_str_mv Sáenz de Urturi, Diego
Buqué, Xabier
Porteiro, Begoña
Folgueira, Cintia
Mora, Alfonso
Delgado, Teresa C
Prieto-Fernández, Endika
Olaizola, Paula
Gómez-Santos, Beatriz
Apodaka-Biguri, Maider
González-Romero, Francisco
Nieva-Zuluaga, Ane
Ruiz de Gauna, Mikel
Goikoetxea-Usandizaga, Naroa
García-Rodríguez, Juan Luis
Gutierrez de Juan, Virginia
Aurrekoetxea, Igor
Montalvo-Romeral, Valle
Novoa, Eva M
Martín-Guerrero, Idoia
Varela-Rey, Marta
Bhanot, Sanjay
Lee, Richard
Banales, Jesus M
Syn, Wing-Kin
Sabio, Guadalupe
Martínez-Chantar, María L
Nogueiras, Rubén
Aspichueta, Patricia
author Sáenz de Urturi, Diego
author_facet Sáenz de Urturi, Diego
Buqué, Xabier
Porteiro, Begoña
Folgueira, Cintia
Mora, Alfonso
Delgado, Teresa C
Prieto-Fernández, Endika
Olaizola, Paula
Gómez-Santos, Beatriz
Apodaka-Biguri, Maider
González-Romero, Francisco
Nieva-Zuluaga, Ane
Ruiz de Gauna, Mikel
Goikoetxea-Usandizaga, Naroa
García-Rodríguez, Juan Luis
Gutierrez de Juan, Virginia
Aurrekoetxea, Igor
Montalvo-Romeral, Valle
Novoa, Eva M
Martín-Guerrero, Idoia
Varela-Rey, Marta
Bhanot, Sanjay
Lee, Richard
Banales, Jesus M
Syn, Wing-Kin
Sabio, Guadalupe
Martínez-Chantar, María L
Nogueiras, Rubén
Aspichueta, Patricia
author_role author
author2 Buqué, Xabier
Porteiro, Begoña
Folgueira, Cintia
Mora, Alfonso
Delgado, Teresa C
Prieto-Fernández, Endika
Olaizola, Paula
Gómez-Santos, Beatriz
Apodaka-Biguri, Maider
González-Romero, Francisco
Nieva-Zuluaga, Ane
Ruiz de Gauna, Mikel
Goikoetxea-Usandizaga, Naroa
García-Rodríguez, Juan Luis
Gutierrez de Juan, Virginia
Aurrekoetxea, Igor
Montalvo-Romeral, Valle
Novoa, Eva M
Martín-Guerrero, Idoia
Varela-Rey, Marta
Bhanot, Sanjay
Lee, Richard
Banales, Jesus M
Syn, Wing-Kin
Sabio, Guadalupe
Martínez-Chantar, María L
Nogueiras, Rubén
Aspichueta, Patricia
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Agencia Estatal de Investigación (España)
Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
Fundación Lilly
Asociación Española Contra el Cáncer
Comunidad de Madrid (España)
Fundación La Caixa
Ministerio de Economía, Innovación y Competitividad (España)
Fundación BBVA
Xunta de Galicia (España)

dc.subject.none.fl_str_mv Adipose Tissue, Brown
Insulin Resistance
Methionine Adenosyltransferase
Obesity
Oligonucleotides, Antisense
Animals
Energy Metabolism
Liver
Mice
NF-E2-Related Factor 2
topic Adipose Tissue, Brown
Insulin Resistance
Methionine Adenosyltransferase
Obesity
Oligonucleotides, Antisense
Animals
Energy Metabolism
Liver
Mice
NF-E2-Related Factor 2
description Altered methionine metabolism is associated with weight gain in obesity. The methionine adenosyltransferase (MAT), catalyzing the first reaction of the methionine cycle, plays an important role regulating lipid metabolism. However, its role in obesity, when a plethora of metabolic diseases occurs, is still unknown. By using antisense oligonucleotides (ASO) and genetic depletion of Mat1a, here, we demonstrate that Mat1a deficiency in diet-induce obese or genetically obese mice prevented and reversed obesity and obesity-associated insulin resistance and hepatosteatosis by increasing energy expenditure in a hepatocyte FGF21 dependent fashion. The increased NRF2-mediated FGF21 secretion induced by targeting Mat1a, mobilized plasma lipids towards the BAT to be catabolized, induced thermogenesis and reduced body weight, inhibiting hepatic de novo lipogenesis. The beneficial effects of Mat1a ASO were abolished following FGF21 depletion in hepatocytes. Thus, targeting Mat1a activates the liver-BAT axis by increasing NRF2-mediated FGF21 secretion, which prevents obesity, insulin resistance and hepatosteatosis.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-03-01
2022
2022-03-01
2023
2023-03-27
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv http://hdl.handle.net/20.500.12105/15706
url http://hdl.handle.net/20.500.12105/15706
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Atribución 4.0 Internacional
http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repisalud
instname:Instituto de Salud Carlos III (ISCIII)
instname_str Instituto de Salud Carlos III (ISCIII)
reponame_str Repisalud
collection Repisalud
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869417567734464512
score 15,81155